Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 20; no. 2; pp. 150 - 151
Main Authors Frank, J, Lang, M, Witt, S H, Strohmaier, J, Rujescu, D, Cichon, S, Degenhardt, F, Nöthen, M M, Collier, D A, Ripke, S, Naber, D, Rietschel, M
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.02.2015
Nature Publishing Group
Subjects
45/43
692/699/476/1799
Antipsychotic Agents - adverse effects
Behavioral Sciences
Biological Psychology
Clozapine - therapeutic use
Drug Resistance - genetics
Drug therapy
Family medical history
Female
Genes
Genetic aspects
Genetic Predisposition to Disease
Genetics
Genomes
Genotype
Health risk assessment
Hospitals
Humans
Letter to the Editor
Male
Medicine
Medicine & Public Health
Mental disorders
Neurosciences
Pharmacotherapy
Physiological aspects
Psychiatry
Psychosis
Psychotherapy
Risk Factors
Schizophrenia
Schizophrenia - drug therapy
Schizophrenia - genetics
Substance abuse treatment
United Kingdom
Switzerland
Germany
United Kingdom > UK
Online AccessGet full text

Cover

More Information
ISSN:1359-4184
1476-5578
DOI:10.1038/mp.2014.56